McKinsey September 23, 2021
Pharmaceutical supply chains have become global and complex. With more outsourcing, new modalities, and novel ways to reach patients, it’s critical to ensure that they can withstand shocks.
In the past two decades, the worldwide value of pharmaceutical goods traded has grown sixfold, from $113 billion in 2000 to $629 billion in 2019.1 Amid this growth, supply chains have become increasingly global, complex, and opaque. More companies are outsourcing production to contract manufacturers, adding new modalities (such as cell therapy), and exploring novel ways to reach patients. For some products, this results in supply chains that are so complex that they start in Asia and circumnavigate the globe twice.
Leading pharma companies have succeeded in shifting their supply...
Today's Sponsors
Today's Sponsor